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CSV consists of a very complex of molecules and demonstrates signiﬁcant cellular activities capable of stimulating immune func-
tions in vivo. The purpose of this study was to analyze the eﬀects of CSV on sex, weight, route of injection and the balance of pro-
and anti-inﬂammatory cytokines in mice. The susceptibility and route of injection were analyzed by lethal (LD50) determination.
The eﬀects of CSV were also analyzed in blood from immunized mice using detection by means of antibodies and mediators pro-
duction.Severalfunctionalbioassayswereemployed:TNFactivitywasassayedbymeasuringitscytotoxicactivityinL929cells,and
other cytokines were assayed by enzyme-linked immunosorbent assay, whereas nitric oxide levels were detected by Griess colori-
metric reactions in sera from BALB/c mice. After injecting subcutaneously, the LD50 presented an increase of the CSV correlation
and similar levels of susceptibility were obtained for female and male from BALB/c mice. Signiﬁcant diﬀerences were observed in
the time-course of cytokine levels. The balance of pro- and anti-inﬂammatory cytokines TNF/IL-10 and IL-6/IL-10 ratios were
signiﬁcantly higher in injected mice group when compared with those obtained for non-injected group. The CSV is poor in anti-
genic composition and it is diﬃcult to get antibodies speciﬁc to neutralizing the lethal factor. The eﬀect of immunization with
0.5 LD50 of CSV on the balance of pro- and anti-inﬂammatory cytokines was measured. The maximum levels of TNF and IL-6,
IFN-γ and NO were observed on days 7 and 21 after immunization, respectively. IL-10 levels peaked between days 21 and 28 after
immunization with CSV. With respect, to balance of pro- and anti-inﬂammatory cytokines it was possible to observe that negative
correlation between serum levels of IL-6/IL-10 and TNF/IL-10 exists. These ratios may possibly reﬂect the balance of pro- and
anti-inﬂammatory cytokines in serum, which may by manifested in the inﬂammatory status during the envenoming processes. In
conclusion, an increase in the serum levels of TNF and IL-6 may be a useful marker for scorpion envenomation.
Copyright © 2006 Vera L. Petricevich. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
INTRODUCTION
Scorpion Centruroides noxius is considered one of the most
dangerous species to humans in Mexico. It is well established
that the predominant lethal action of scorpion venom exerts
av a r i e t yo fe ﬀects on excitable tissues. These venoms exert
av a r i e t yo fe ﬀects on excitable tissues and exhibit enormous
variety according to the species. Victims of scorpion stings
presented perturbation of the nervous, cardiovascular, and
respiratory systems [1]. The speciﬁc signs are directly related
to the venom components, the patients stung by scorpions
may develop a systemic inﬂammatory response syndrome,
and the balance of cytokines released may also play a major
role in the pathogenesis [2–4].
A successful immune response agent on constructed us-
ing some of their structural components is dependent on
the activation of an appropriate set of immune eﬀectors
function. The two arms of this response, cell and antibody-
mediated immune responses, though both are dependent on
aproperantigenpresentationbyantigen-presentingcells,are
regulated by distinct subsets of CD4+ helper T cells that are
divided in two main subsets, Th1 and Th2 [5]. These two
subsets of the Th cells diﬀer in the eﬀectors functions and
mainly in the repertoire of cytokines that they secrete in re-
sponse to antigenic stimulation. Th1 cells exclusively secrete
interferon-gamma(IFN-γ),interleukin-12(IL-12),andIL-2,
whereas Th2 cells secrete IL-4, IL-5, IL-6, IL-10, and IL-13.
There are also some cytokines such as IL-3, tumor necro-
sis factor (TNF-α), which is common to both subsets [5].
Th1 cells protect against intracellular microorganisms, in-
duce the transient production of IgG2a opsonizing antibod-
ies, and promote delayed-type hypersensitivity responses. In
contrast, Th2 cells protect against extracellular pathogens,
which are mainly eradicated by neutralizing antibodies that
includetheinductionofIgEandtheIgA.Cytokinesaredirect
mediators of inﬂammation and inﬂuence the progress and
directionofmanyimmunologicalreactions[6].Theymaybe
divided into proinﬂammatory cytokines such as TNF, IL-1,2 Mediators of Inﬂammation
and IL-8, that include the mobilizing immune system cells to
proliferate and produce more cytokines creating an inﬂam-
matory cascade, and as anti-inﬂammatory cytokines, such as
IL-10 whose function is to dampen or control the inﬂamma-
tory response.
At a local site of injury or infection and during the initial
appearance of pro- and anti-inﬂammatory mediators in the
circulation,thebeneﬁcialeﬀectsofthesecompoundscounter
balance their eﬀects. The production of pro- and anti-
inﬂammatory cytokines is strongly controlled by complex
feedback mechanisms [5, 7]. Proinﬂammatory cytokines are
primarily responsible for initiating an eﬀect against exoge-
nous pathogens. However, excessive production of these me-
diators may signiﬁcantly contribute to shock, multiple organ
failure, and death [5, 8, 9]. In contrast, anti-inﬂammatory
cytokines are crucial for down regulating the incremented
inﬂammatory process and maintaining homeostasis for the
correct functionating of vital organs [10, 11]. A balanced
ratio of pro- and anti-inﬂammatory cytokines is important
forappropriate immune response;excessiveinﬂammation or
hyporesponsiveness can lead to complications.
Many diﬀerent cytokines have been described in severe
envenomation and among these, TNF-α, IL-1, and IL-6, that
seem to be the major proinﬂammatory cytokines and sec-
ondarily of anti-inﬂammatory cytokines, such as IL-10 [3].
TNF-α is one of the most important cytokines involved in
the pathophysiology of envenomation. IL-1 and TNF-α are
synergistic and share many biological eﬀects in sepsis [12].
The role of IL-6 is controversial; it has both pro- and anti-
inﬂammatory properties [13]. It down-regulates the syn-
thesis of IL-1 and TNF and has little eﬀect on the synthe-
sis of IL-10 [14, 15]. IL-6 also inhibits the expression of
the other proinﬂammatory cytokine, TNF-α, thus introduc-
ing a controlling step in the ampliﬁcation of inﬂammation
[16].
Cytokine production in severe envenomation has been
studied, and it seems that two forces, pro- and anti-
inﬂammatory cytokines, are elevated during these processes.
However, their clinical signiﬁcance and prognostic value
have not been elucidated [3]. During envenomation, both
pro- and anti-inﬂammatory cytokines response, although
there is a shift toward increased anti-inﬂammatory and re-
duced proinﬂammatory cytokine production. It seems that
a complex network of interactions between diﬀerent cy-
tokines and possibly other components of the immune re-
sponse takes place during severe envenomation. The patho-
genesis of envenomation is characterized by an imbalanced
activation of Th1 and Th2 cells. IL-10 is the main bi-
ological function to limit and terminate the inﬂamma-
tory responses blocking the Th1-derived cytokines. Inade-
quate concentrations of IL-10 can result in excess inﬂamma-
tion.
The purposes of the present study are (1) to analyze the
inﬂuence of sex, weight, and route of Centruroides scorpion
venom (CSV) injection, (2) to investigate the symptoms, an-
tibody production, and mediators released following injec-
tion of whole CSV, and (3) to evaluate the inﬂammatory sta-
tus during the envenoming processes.
MATERIALS AND METHODS
Materials
Actinomycin D, o-phenylenediamine (OPD), naphthylene-
diamine (NADPH), sulphonylamide (FAD), NO2 reduc-
tase, fosforic acid, antimouse IgG peroxidase conjugate
were supplied by Sigma, St Louis, MO, USA. Fetal calf
serum (FCS) was obtained from Equitech-Bio, Inc. Ker-
rville.Avidin-horseradishperoxidase,2,2
 -azino-bis(3-ethyl-
benzthiazoline-6-sulfonic acid) (ABTS) were supplied by
Sourthen Biotechnology Associates Inc., USA. Antimouse
IL-6 (clones MP5-20F3 and MP5-32C11), rIL-6, antimouse
IL-10 (clones JES5-2 A and SCX), rIL-10, antimouse IFN-
γ (clones XMG1.2 and AN18), rIFN-γ were purchased from
Pharmingen, Calif, USA.All otherreagents wereof analytical
grade.
Animals
BALB/c female mice (12–20g body weight) were supplied by
Bioterio (Instituto de Biotecnolog´ ıa, UNAM, Mexico). Mice
were maintained and used according the animal welfare in-
ternational recommendation for animal welfare (Committee
Members, International Society in Toxicology, 1992) [17].
Venom
Lyophilized crude venom from adult specimens of Cen-
truroides noxius scorpion venom (CSV) are pooled from
more than 20 adult specimens and referred to as CSV. Cen-
truroides noxius scorpion venom was generously given by Dr
Jorge Paniagua (Laboratorio Silanes, DF, Mexico).
Lethality
The lethal dose (LD50) was estimated by injecting intraperi-
toneally and/or subcutaneously with diﬀerent doses of CSV
into groups of ﬁve BALB/c female and male mice with diﬀer-
entages,sex,andweights.Deathsoccurringduring24hwere
recorded and LD50 was calculated by probit.
Effectsofcentruroidesscorpionvenom(CSV)on
cytokinelevels
Groups of mice were injected subcutaneously with diﬀerent
amounts of CSV, dissolved in 0.1mL of saline solution. Con-
trol mice received 0.1mL of saline solution. Since mortality
was of a fraction of the injected animals, the number of mice
per experimental group ranged between 5 and 15 in order to
obtain blood samples from at least ﬁve mice for each time
interval. Mice were bled at diﬀerent times, and sera were sep-
arated and stored at
￿20
ÆC until use.
Immunizationofmice
The immunization and bleeding schedules were as fol-
lows. Group of 15 mice were subcutaneously immunized atVera L. Petricevich 3
weekly intervals for three times with saline solution, or CSV
(0.5LD50 = 7.75μg/mouse), respectively. After diﬀerent time
intervals, animals were bled from the retro-orbital to eval-
uate the immune response. Sera samples were stored frozen
at
￿20
ÆC until use. One week after the third immunization
the control or immunized mice were challenged intraperi-
toneally with 15.5μg( 1L D 50)o r7 7 .5μg( 5L D 50) per animal
of CSV. The mortality was recorded at 24, 48, and 72h after
the challenge.
Antibodytitration
Speciﬁc antibodies against antigens used for the immuniza-
tion were estimated by standard ELISA, which was per-
formed as described by Gebara et al [18]. In brief, ELISA
plates were coated with 100μL of the appropriate antigen
CSV. The antigen were diluted to a concentration of 2μgp e r
well in 0.1M NaHCO3,p H8 .2, and incubated at room tem-
perature for 6h. After this time, the wells were washed three
times with PBS containing 0.05% Tween-20 (PBS/Tween),
thenblockedbyadditionofblockingbuﬀer10%defatedmilk
and 2% fetal calf serum (FCS), and the plates were incubated
at 4
ÆC for a further period of 18h. After washing the wells
with PBS/Tween, the plates were incubated with serial di-
lutions of sera from mice non-injected and/or immunized
for diﬀerent times for 2h at room temperature. After wash-
ing the wells, 50μL of 1 : 1000 dilution of biotinylated goat
antimouse immunoglobulin avidin-horseradish peroxidase-
conjugated were added to each well. The plates were incu-
bated 2h at room temperature, the wells were washed ﬁve
times with PBS/Tween, and 50μL of the substrate buﬀer
containing 0.2% o-phenylenediamine and 0.015% H2O2 was
added to each well. The reaction was stopped with 4.5M
H2SO4, and the absorbance at 490nm was measured in a mi-
croplate reader (BIO-RAD 3550-UV model). Sera samples
were considered to be positive for antibody response if the
absorbance value was greater than 0.1 and the ratio between
sample optical density absorbance and control absorbance
was 2 or more.
Cytokineassay
IL-6, IL-10, and IFN-γ were assayed by two-site sandwich
enzyme-linked immunosorbent assay ELISA method as de-
scribed by Schumacher et al [19]. In brief, the wells of
ELISA plates were coated for 6 at room temperature with
100μLo f0 .1M sodium carbonate buﬀer (pH 8.2) contain-
ing the appropriate dilutions of the ﬁrst antibody rat anti-
mouse IL-6 antibody MP5-20F3, rat antimouse IL-10 an-
tibody JES5-2A or rat antimouse IFN-γ antibody XMG1.2.
The wells were then washed with 0.1% phosphate-buﬀered
saline (PBS-Tween-20) and blocked with 100μL of 10% FCS
in PBS for 2h at room temperature. After washing, dupli-
cate sera samples of 50μL were added to the well. After
18h of incubation at 4
ÆC, the wells were washed and in-
cubated with 100μL( 2μg/mL) of biotinylated monoclonal
antibodies rat antimouse IL-6 MP5.32C11 or antimouse IL-
10 SCX or antimouse IFN-γ AN18, as second antibodies by
45min at room temperature. After washing, 50μL of avidin-
horseradish peroxidase conjugate were added and the plates
were incubated for a further 30min period also at room
temperature. After washing, 50μLo fs u b s t r a t eb u ﬀer con-
taining 150μg/mL of 2,2
 -azino-bis(3 ethyl benzthiazoline-
6-sulfonic acid) (ABTS) were added to each well. The re-
action was stopped after 30min with N,N-dimethyl for-
mamide (DMF) plus sodium dodecyl sulfate (SDS) and the
absorbance was measured at 405nm in a microplate reader.
Sera cytokine levels were determined using standard curve
established with the appropriate recombinant cytokines (ex-
pressed in pg/mL). The minimum levels of each cytokine de-
tectable in the conditions of the assays were 50pg/mL for IL-
6, IFN-γ, and IL-10.
TNF was assayed by evaluating its cytotoxic activity on
the target ﬁbroblast cell line L-929, as described by Ruﬀ and
Giﬀord [20]. To monolayer of L-929 cells in medium RPMI-
1640 supplemented with 5% FCS (3–5
￿ 104 cells per well)
50μL of serum samples serially diluted in RPMI-1640 con-
taining 1.0μg/mL of actinomycin D were added. After incu-
bation for 18h at 37
ÆC in a humidiﬁed atmosphere of 5%
CO2, the supernatants were removed and the remaining liv-
ing cells were assessed after ﬁxing and staining with crystal
violet (0.2% in 20% methanol). The absorbance at 620nm
of each well was red in a microplate reader. Cytotoxic was
calculatedasfollows:(Abscontrol
￿Abssample /Abscontrol)
￿100.
TNFactivitywasexpressedinnanogramspermilliliter,using
a standard curve prepared with recombinant TNF-α. The de-
tection limit of this assay was 5pg/mL.
Nitritedetermination
The nitrite levels in female mice sera as an indication of NO
production were determined as previously described [21]. In
brief, 40μL of each mice sera sample were incubated in a 96-
well,ﬂat-bottomedplatewith40μLofthereductionsolution
(NADPH, 1.25ng/mL; FAD 10.4ng/mL;KH 2PO4,0 .125M)
containing 0.5U of NO 2
  reductase for 2h at 37
ÆC. After
this time, 80μL of Griess reagent (0.1% naphthylenediamine
hydrochloride, 1% sulphonylamide, 3% H3PO4)w e r ea d d e d
to each well. The optical densities were measured at 540nm
in a microplate reader and NO2
  concentrations were deter-
mined using a standard curve of NaNO3 ranging from 1.25
to 275nM (expressed as nMol/mL).
Statisticalanalyses
Results are presented as the mean
￿ standard deviations
(SD). Statistical analysis was performed by the Student’s t-
test, and the level of signiﬁcance was set at P<. 05.
RESULTS
EffectofCSVonfemaleandmalemice
Sexandrouteofinjection
To verify whether the mouse sex and route of injection
showed an eﬀect on mortality, CSV was injected intraperi-
toneally or subcutaneously, at diﬀerent concentrations, in4 Mediators of Inﬂammation
20
15
10
5
0
M
o
u
s
e
(
μ
g
)
Female Male
BALB/c
IP
Subcutaneous
Figure 1: Eﬀects of CSV toxicity according to mouse sex. Groups
of female mice from diﬀerent strains, 16–20g of body weight, were
injectedintraperitoneallyorsubcutaneouslywithdiﬀerentamounts
ofCSV.TheLD50 valuewascalculatedbyprobitanalysisofthedeath
occurring within 24h of venom injection. The experiment was re-
peated twice and each point represents the values of pooled sera
from 5 animals
￿ SD.
female or male BALB/c strain mice to determine the me-
dian lethal doses (LD50). Figure 1 shows that the LD50 of
CSV in BALB/c female mice by the intraperitoneally and
subcutaneously routes were 12.8a n d1 5 .5μg/mice, respec-
tively. When mice received an intraperitoneally and/or sub-
cutaneously injection of one LD50 of CSV, a fraction of the
injected animals died. The time-course of mortality diﬀered
between the routes. In CSV intraperitoneally injected female
mice, the majority of deaths occurred within the ﬁrst 2h. In
contrast, most of the deaths occurring after subcutaneously
injection were observed at later time intervals of 4 and 5h
(results not shown). No deaths were observed in injected
with saline solution. No diﬀerent sensibilities for various
amounts of venom were observed in both groups of animal
injected intraperitoneally or subcutaneously (Figure 1).
Bodyweight
Toverifywhetherbodyweightshowedaneﬀectonmortality,
BALB/c female mice were injected intraperitoneally or sub-
cutaneously with diﬀerent CSV concentrations. These ani-
mals were distributed in three groups, with diﬀerent body
weights. As body weight increased, it was possible to observe
a decrease in susceptibility for all groups (Figure 2). When
mice received an intraperitoneally or subcutaneously injec-
tion of 1 LD50 of CSV, the time-course of mortality did not
diﬀer between the groups studied. In all groups, the major-
ity of deaths occurred within ﬁrst 2 and 4h for intraperi-
toneally and subcutaneously routes, respectively. Death was
usually preceded by certain signals or symptoms such as sali-
vation and tremor. Groups of BALB/cfemalemice of 16–20g
of body weight were injected subcutaneously with 1 LD50
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Figure 2: Eﬀect of CSV on body weight. Groups of female mice
from BALB/c strain, with diﬀerent body weights, were injected in-
traperitoneally and/or subcutaneously with diﬀerent amounts of
CSV. Deaths occurring during 24h were recorded and the LD50
value was calculated. The experiment was repeated twice and each
point represents the values of pooled sera from 5 animals
￿ SD.
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Figure 3: Symptoms. Groups of 15 female mice from the BALB/c
strain, 16–20g of body weight, were injected subcutaneously with
1L D 50 of CSV. Each point represents the percent animal number
with salivation and/or tremor. The experiment was repeated twice
and each point represents the values of pooled sera from 5 animals
￿ SD.
of CSV, and at diﬀerent intervals of time speciﬁc signs were
observed (Figure 3). The maximum number of animals that
presented salivation and tremor was observed at 120min
post-injection, decaying thereafter.
Mediatorsproduction
To determine mediators production, groups of BALB/c
female mice with 16–20g of body weight were injectedVera L. Petricevich 5
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Figure 4: Mediators production on mice with moderate symptoms. Groups of mice were injected with diﬀerent amounts of CSV. Mice
were bled at diﬀerent time intervals after injection and sera were separated for cytokine studies determined as described in “Materials and
Methods.” Experiments were repeated twice and each point represents the value of pooled sera from 5 animals
￿ SD. Statistical diﬀerences
between the treatments were marked with asterisk (P<. 001).
subcutaneously with 1 LD50 of CSV and bled after diﬀerent
time intervals. Mice injected with saline solution had unde-
tectable levels of all mediators assayed in the serum. These
animals were divided into two groups: one that showed se-
veresymptomsofenvenomation,andtheotherthatdidshow
moderate symptoms. The peak sera IL-6, IFN-γ, and IL-10
levels were signiﬁcantly elevated in all injected groups com-
pared with those obtained for non-injected (P<. 001) (data
not shown). The maximum levels of cytokines in injected
sera mice that showed severe symptoms of envenomation
could be observed until 12h after injecting, decaying there-
after (data not shown). Figure 4 shows that the maximum
levels of IL-6 at 24h decaying thereafter. The highest levels of
TNF and IFN-γ were observed between 24–48h (Figure 4).
Interestingly, the peak maximum of IL-10 production was
observed at 48h after injection (Figure 4).
To evaluate the balance of pro- and anti-inﬂammatory
cytokines TNF/IL-10 and IL-6/IL-10 ratios were determined.
TNF/IL-10 ratios were signiﬁcantly higher in injected mice
group (P<. 001), at 24 and 48h when compared with those
obtained for non-injected group (Table 1). In contrast, IL-
6/IL-10 ratios were discreet incremented after 24h of injec-
tion, decaying thereafter.
Taking these results, it was possible to establish the op-
timal conditions for BALB/c mice exposure to CSV. Thus
in the following set of experiments, the female groups were
treated by subcutaneously route with 0.5L D 50.
Table 1: Balance of pro- and anti-inﬂammatory cytokines. Groups
of mice were injected subcutaneously with 1 LD50 of CSV, nonin-
jected group was treated with saline solution. Sera cytokine concen-
trations (pg/mL) in injected groups and/or noninjected group at 24
and 48h of envenoming evaluation.
TNF/IL-10 IL-6/IL-10
0h
Injected groups 00
Non-injected groups 00
24h
Injected groups 17.44(a) 1.39(b)
Non-injected groups 4.50 .90
48h
Injected groups 16.66(a) 0.96(b)
Non-injected groups 4.50 .90
(a)P<. 001, (b)not signiﬁcant.
Immuneresponseinducedinmice
Antibodyproductionandprotection
To verify if the diﬀerent abilities of CSV to stimulate the
mouse immune system were due to the kinetics of antibody6 Mediators of Inﬂammation
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Figure 5: Antibody response in immunized mice. Immunizations
were administered as described in Materials and Methods. Groups
of mice immunized were bled on days 28 and the antiserum was
tested on ELISA plates coated with CSV as described in “Materials
and Methods.” The experiment was repeated twice and each point
represents the value of pooled sera from 5 animals
￿ SD.
and mediators production, groups of BALB/c female mice
were weekly immunized subcutaneously with 0.5L D 50 of
CSV each seven days. At days 7, 14, 21, or 28 after immu-
nization, the animals from each corresponding group were
bled, the sera pooled and used for antibody and mediators
kinetic production. Figure 5 shows that IgG levels a discreet
increaseafterimmunization withCSV. Thelevelsofantibod-
ies in mice immunized with CSV increased up to 21 days,
decaying thereafter (Figure 5).
TotestwhetherCSVthediscreettheantibodyproduction
was also reﬂected in vivo upon challenge with CSV. Groups
of mice immunized as described above were challenged with
1o r5L D 50 of the CSV per animal, and the protection was
evaluated. As is shown in Table 2 in control female mice the
lethalityofthevenomwasnotneutralizedat50%and0%for
1a n d5L D 50 of dose challenge, respectively. In contrast, for
groups of mice previously immunized with CSV, the lethality
percent neutralized were 60% and 20%, for 1 and 5 LD50 of
dose challenge, respectively (Table 2). These results suggest
that the CSV is poor in antigenic composition and it is diﬃ-
cult to get antibodies speciﬁc to neutralize the lethal factor.
None of the mice immunized showed any side-eﬀects or,
particularly, any toxicity symptoms during the immuniza-
tion program. After challenge the toxic symptoms were ob-
served in CSV groups. The evolution of clinical manifesta-
tions of envenoming in immunized groups was observed in
minor of the animals with salivation and tremor after chal-
lenge. When comparing the number of animals with sali-
vation and tremor between the nonimmunized groups and
groups immunized with CSV, both challenged with 5 LD50
per animal of the venom, a lower number of animals pre-
sented this symptom observed in the latter group (data not
shown).
Table 2: Mortality ratio (number dead/number tested) of mice im-
munized with scorpion venom. Groups of mice were weekly sub-
cutaneously immunized with 0.5L D 50 of CSV. One week after the
third injection the animals were intraperitoneally challenged with 1
or 5 LD50 of CSV per animal. Nonimmunized mice were challenged
with 1 or 5 LD50 per animal. The mortality was recorded at 24, 48,
and 72h.
N◦dead/N◦tested
Group Dose of challenge (% mortality)
1 LD50 5 LD50
Nonimmunized 7/15 (50) 15/15 (100)
Immunized 6/15 (40) 12/15 (80)
EffectofimmunizationwithCSVonmediatorproduction
Sera from mice immunized subcutaneously with 0.5L D 50 of
CSV were assayed for cytokines and NO on days 7, 14, 21,
or 28 after immunization. Figure 6 shows that TNF produc-
tion was signiﬁcantly higher for sera from mice immunized
with CSV when compared with those obtained from control
group (P<. 01). The highest levels of TNF produced in sera
from mice immunized with CSV were observed on 7th day
after immunization. The peak of IL-6 production was ob-
served on day 21 after immunization for animals immunized
with CSV (Figure 6). Figure 6 also shows that highest levels
of IFN-γ were observed on days 14 and 21 after immuniza-
tion. On day 21 after immunization, there was a signiﬁcant
increase in the production of IFN-γ in mice immunized with
CSV (P<. 001) when compared with those obtained from
nonimmunized groups. The peak of IL-10 production was
observed on days 21 and 28 after immunization with CSV
(Figure 6). The IL-10 levels were signiﬁcant higher for sera
from mice immunized with CSV when compared with those
obtained from control group (P<. 001).
TheseraNOlevelswereassessedbydeterminingthecon-
centration of NO2
 . At all time intervals of immunization,
mice presented elevated levels when compared with those
observed in group mice injected only with saline solution
(Figure 6)( P<. 001). The highest levels of NO2
  produc-
tionwereobservedonday21afterimmunizationforanimals
immunized with CSV.
The balance of pro- and anti-inﬂammatory cytokines
also was determined for the groups of animals immunized
subcutaneously with 0.5L D 50 by diﬀerent intervals of time.
The immunization with CSV induced a marked increment
in TNF/IL-10 and IL-6/IL-10 ratios sera levels, with an in-
crease occurring within the ﬁrst 14 days, decaying thereafter
(Figure 7).
DISCUSSION
In Mexico, Centruroides noxius scorpion is responsible for an
important number of accidents among humans. Scorpion
venom consists of complex mixtures of several toxins that
exhibit various biological activities. The already or experi-
mentally injected animals may exhibit signs and symptomsVera L. Petricevich 7
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Figure 6: Kinetics of pro- and anti-inﬂammatory cytokines. Groups of mice were immunized subcutaneously with 0.5L D 50. Sera samples
were collected on days 0, 7, 14, 21, and 28 days after immunization. The cytokines levels were determined as described in “Materials and
Methods.”Theexperimentwasrepeatedtwiceandeachpointrepresentsthevaluesofpooledserafrom5animals
￿SD.Statisticaldiﬀerences
between the treatments were marked with asterisk (P<. 001 for IL-6, IL-10, IFN-γ, and NO) and (P<. 01 for TNF).
whichinvolvethecentralnervoussystems,stimulationofau-
tonomic system, and, occasionally, respiratory and heart fail-
ure, and even death [4, 22]. Various factors can contribute to
themanifestationofspeciﬁcsignsandsymptomsasreactions
to stings with respect to the scorpion venom toxicity which
m a yv a r y[ 23]. However it has been demonstrated that other
factors may also be considered as clinical signs such as the
age or size of the victims, for example, children are normally
more severely aﬀected, the site of the injection, and the indi-
vidual’s vulnerability to venom [4, 22, 24, 25].
The present study was designed to know the eﬀects of
CSV on mice with respect to the route and doses of venom
administered, the severity of envenomation and the medi-
ators’ production were studied and discussed. The eﬀect
of CSV was studied to evaluate the susceptibility between
female and male from BALB/c strain and the eﬃcacy of the
injection route. This study compared the eﬀect of injecting
CSV intraperitoneally or subcutaneously; and no diﬀerent
distribution of susceptibility was observed among analyzed
animals. With respect to an increase in age and body weight,
ad i ﬀerent susceptibility was observed. The time-course of
mortality did not diﬀer between the groups studied.
The rapid absorption and distribution of scorpion
venom toxins indicate that scorpion envenoming is an ex-
treme emergence case. The victims may exhibit signs and
symptoms involving the central nervous system stimulation
of the autonomic nervous system, and occasionally respira-
tory and heart failure, even death [1, 4]. Speciﬁc signs and
symptoms are usually manifested very soon after envenom-
ing and develop into systemic inﬂammatory very soon after8 Mediators of Inﬂammation
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Figure 7: Kinetics of balance of pro- and anti-inﬂammatory cy-
tokines. Groups of mice were immunized subcutaneously with 0.5
LD50 of CSV as described above. The cytokines levels were deter-
mined as described in “Materials and Methods.” The TNF/IL-10
and IL-6/IL-10 ratios were calculated. The experiment was repeated
twice and each point represents the values of pooled sera from 5
animals
￿ SD.
envenoming and develop into systemic inﬂammatory mani-
festations and organ failure. Salivation and tremor are rarely
absent in scorpion envenomation. In this study the clini-
cal manifestations of envenoming in animal groups injected
with CSV showed that the symptom of salivation and tremor
can be observed until 120min after challenge. The presence
of clinical signs in group mice injected with CSV was corrob-
orated by a signiﬁcant increase of mediators’ levels. Increas-
ing evidence from animal studies as well as clinical experi-
ence show that the involvement of the inﬂammatory cascade
and release of cytokines play a major role in the pathogenesis
of many envenoming syndromes.
Various studies have been revealed that most cytokines
are a group of regulatory and immunomodulatory proteins
involved in a number of physiological processes. The role of
cytokines during inﬂammation is both initiation and ﬁne-
turningofthewholeprocess:somecytokinesinitiateandam-
plify the response, others sustain or attenuate it, and some of
them cause it to resolve.
The present study showed that in animal groups with se-
vere symptoms of envenomating, the CSV is capable to in-
duce the secretion of large amounts of TNF, IL-6, and IFN-γ.
High levels of TNF-α and IL-6 are rapidly induced early in
an envenomation and can be associated with a compromised
prognosis for shock in animals. If they were over expressed,
they may exacerbate the severity of an envenomation con-
dition. In contrast, IL-10 inhibits the Th1-derived cytokines.
Itsmainbiologicalfunctionistolimitandresolvetheinﬂam-
matory responses.
Several studies have shown that some venom may induce
ad i ﬀerential release of cytokines, with the theoretical poten-
tial to either accelerate or down regulate cytokine-induced
organ dysfunction or shock. Snake and spider venoms seem
to induce IFN-γ, TNF, and IL-6 release, [26–28]. Conversely,
Ts e r r u l a t u sscorpion venom has been shown to down-
regulate TNF-α production [25] .I nar e c e n ts t u d y ,c o n -
ducted with patients with diﬀerent envenomation phases
showed increases in TNF-α and IL-6 levels [2]. However, the
pathogenesis of the envenomation is rather complex, involv-
ing a great variety of inﬂammatory molecules and coagula-
tion factors, and therefore, the correlation between venom-
induced release of cytokines and outcome is not clear. En-
venomation is presumed to be driven by the release of proin-
ﬂammatory cytokine, mainly TNF-α and IL-6, while many
of compensatory anti-inﬂammatory response may be at-
tributed to the biological eﬀectsof the anti-inﬂammatory cy-
tokines, such as IL-10.
In order to evaluate the diﬀerential eﬀects of CSV on the
pro- and anti-inﬂammatory cytokine proﬁle, this study was
organizedsoastoenrollahomogeneousmiceincludingcon-
trolanimalgroup.Intheroleofinjectedgroup,therewerean
increment increase in the inﬂammatory response and a par-
allel decrease in the anti-inﬂammatory response, as charac-
terized by an increase in the TNF/IL-10 and IL-6/IL-10 ratios
24haftervenominjection.Nosuchdiﬀerenceswerenotedin
the control group. The anti-inﬂammatory eﬀect of CSV was
corroborated with the increase of IL-10 levels.
Most importantly, in the study of the serum baseline,
TNF-α levels detected a very signiﬁcant increase in the TNF-
α/IL-10 ratio until 24h, due to a modest decrease in serum
TNF-α levels and an increase in serum IL-10 levels at 48h
after the venom injection. In contrast, the IL-6/IL-10 ratio
and the cytokine levels were unchanged at all time points,
while IL-6 levels were signiﬁcantly higher, and serum IL-10
levels and the IL-6/IL-10 ratio were signiﬁcantly lower than
thoseinthenon-injectedgroup.Itseems,thereforethatthere
is a later (at 48h of injection) no immunomodulatory ef-
fect of CSV in severe envenomation, especially if there is a
massive production of IL-6, which is rapidly reversed, but
not for TNF-α. It is accepted that the envenomation has
a bimodal nature and is characterized by a primary rather
brief proinﬂammatory phase, followed by a sustained anti-
inﬂammatory phase.
This study was designed in order to know the inﬂam-
matory mediators following CSV immunization, which play
roles in the ampliﬁcation of both humoral and cell-mediated
immune responses; and subsequently several strategies for
applying injections were tested.
With respect to the antibodies production, the CSV is
poor in antigenic composition and it is diﬃcult to get an-
tibodies speciﬁc to neutralize the lethal factor results shown
in Table 2. As well as the humoral immune response, the cy-
tokines were also evaluated.
TheimmunizationwithCSVwascapabletostimulatethe
production of cytokines that may be directly involved and
contribute to pathophysiologic changes in envenoming. The
present study showed that mice immunized subcutaneously
with 0.5L D 50 of CSV showed the levels of TNF increasing
until 7 days after venom. TNF-α plays a role in the regulation
ofmanybiologicalresponsesinvivo,andhasbeenimplicated
in a wild range of pathological conditions, including the hostVera L. Petricevich 9
response to sepsis, cachexia and the acute phase response to
infection, trauma, and death. In patients with sepsis, the lev-
els of TNF in the circulation increase proportionally with the
degree of hypotension and organ failure [26, 29, 30].
This study also showed that the levels of IL-6 and IFN-γ
increased between 14 and 21 days. It is an inﬂammatory cy-
tokine with multiple eﬀects including the ability to stimulate
or to enhance the diﬀerentiation and proliferation of B and
T cells, respectively [31, 32], the production of acute phase
proteins by hepatocytes [33] and the toxicity of neutrophils
[34]. IL-6levels arealso elevatedin animalsand humans cor-
relate with the degree of disease severity [30]. In some exper-
imental model, the amount of IL-6 appears to be under the
control of IL-1 and TNF [35–37]. The observation that high-
est elevations of IL-6 preceded the decrease of TNF, obtained
at 14 days, suggests a role as a negative modulation TNF pro-
duction in this model. Diﬀerent studies have shown that the
speciﬁc IFN-γ is expressed in response to venom adminis-
tration and regulated by IL-10 in vivo [26–28]. In agreement
with this, high IFN-γ levels were also observed in mice in-
jected with CSV.
One cytokine that has been shown to aﬀect the modu-
lating activity for the production of other cytokines is IL-10,
as this cytokine can down-regulate the expression of TNF-α
and other inﬂammatory cytokines [38] and probably plays
such role in CSV envenomation. Speciﬁcally the highest IL-
10 levels in immunized mice were associated with low lev-
els of IFN-γ. In this study, as well as other, in agreement
with that the time-dependent increase in IL-10 after injec-
tion with CSV. These results, obtained and combined with
the observation that higher levels of TNF and IL-6 are reg-
ulated by IL-10, would suggest a direct correlation cytokine
balance. Interestingly, IL-10 is expressed in elevated concen-
trations during sepsis [39]. The expression of IL-10 is more
eﬀective in less severe sepsis in regulating inﬂammatory cy-
tokines. These data suggest that production of IL-6 and TNF
is regulated by IL-10, which in turn is under the control of
IFN-γ produced by activated T cells and NK cells [40]. This
ﬁnding is not surprising, as other mediators have previously
beenshowntocontributeto pathophysiologic changesin en-
venomation.Allcytokinesmeasuredshowedtransientproﬁle
characterized by a rapid increase to peak levels, followed by a
slower decline.
While some cytokines contribute to the demise of the
host, in contrast, others appear to protect the host. One must
be cautious with such a strict classiﬁcation because whether
a cytokine is harmful or beneﬁcial to the host is dependent
on the dose and time of venom administration.
With respect to the proinﬂammatory cytokines, they in-
duce local and systemic inﬂammatory manifestations which
include fever, an acute-phase response, and the induction of
system shock in severe inﬂammatory response. A consider-
able body of evidence indicates that together with an impor-
tant pro- and anti-inﬂammatory response contributes. The
balance of inﬂammation by these cytokines and cytokine in-
hibitors is complicated by the fact that the immune system
has redundant pathways with multiple elements having sim-
ilar physiologic eﬀects.
The hypothesis is that envenomation is better distin-
guished by the balance of inﬂammatory mediators rather
than by the concentration of a single mediator alone. This
studyshowsthatseverityofenvenomingisassociatedwithan
altered balance of inﬂammatory cytokines, and this altered
balance has a signiﬁcant impact on severity of envenoming.
Single expression alone such as early TNF expression at the
primary site of inﬂammatory did not distinguish between
diﬀerent doses of venom. Thus, there is a close link between
the severity of envenomated and the balance of inﬂamma-
tory cytokines. Various studies have repeatedly shown that
TNF and IL-1 play a central role in the progression of the
sepsis cascade [41]. In the generation of this cascade, have
been implicated multiple peptide mediators, that leading to
the recruit must and activation of a variety of inﬂammatory
cells [42, 43].
The present study shows that the reactions to envenom-
ing were associated with age, body weight, and route of in-
jection and that they are particularly prominent in the acti-
vation of IL-6, TNF, and IL-10, which were signiﬁcantly el-
evated at 48h compared with the levels in those sera who
were subsequently shown to be controlled. To date, the in-
teraction between pro- and anti-inﬂammatory cytokines in
response to envenomation remains a controversial subject.
Mostevidence,includinginthepresentﬁndingspointstothe
operation of a feedback or counter-regulatory mechanism.
IL-6 and TNF-α are potent proinﬂammatory cytokines and
are responsible for eliciting a strong inﬂammatory reaction,
which, if left uncontrolled, may lead to severe hypotension
multiple organ dysfunction, and death [5]. This proinﬂam-
matory state of acute phase response to envenomation will
ultimately trigger a compensatory anti-inﬂammatory reac-
tion involving antagonist mediators such as IL-10. van der
Poll et al [44] reported that in humans, the release of IL-10
by Th2 cells, B cells, and macrophages has been shown to be
upregulated by circulating TNF-α.
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